India and Brazil are reporting the most new infections each day. however, worldwide infection rates are still rising in 30 countries. On Monday, the Food and Drug Administration authorized the Pfizer-BioNTech vaccine for 12- to 15-year-olds, further expanding vaccine access in the U.S. While there are still hotspots in some parts of the country, the overall number of new infections and deaths are precipitously declining.Īfter a fall and winter surge in hospitalizations and deaths in Los Angeles County, the region is now on track to vaccinate 80 percent of adults by the end of July. Laura Flynn: I’m Laura Flynn, supervising producer at The Intercept.Īt this point in the U.S., more than 50 percent of people have received at least one Covid-19 vaccine shot. By claiming the same monopoly IP rights on Covid-19 therapeutics and vaccines as other drugs, the industry has perpetuated a market of scarcity and profiteering when a collaborative global response is needed. This week on Intercepted: Intercept investigative journalists Sharon Lerner and Lee Fang discuss how the pharmaceutical industry has ruthlessly fought to maintain IP protection from the beginning of the pandemic despite global calls to share knowledge and know-how to end the crisis as quickly as possible.

In response, Bio, a trade association representing biotechnology companies, issued a statement saying, “The United States has unfortunately chosen to set a dangerous precedent with these actions.” A week ago, the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines.

Covid monopoly game online